Lycia Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	Current	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Debt / Equity Ratio	-0.02	-0.07	-0.32
Debt / EBITDA Ratio	-0.10	-0.19	-0.80
Debt / FCF Ratio	-0.09	-0.15	-0.82
Net Debt / Equity Ratio	0.92	0.63	1.45
Net Debt / EBITDA Ratio	3.67	1.78	3.59
Net Debt / FCF Ratio	3.59	1.39	3.67
Quick Ratio	12.26	-	29.11
Return on Equity (ROE)	22.73%	32.17%	34.01%
Return on Assets (ROA)	-	-37.50%	-17.56%
Return on Invested Capital (ROIC)	-	-	-22.26%
Return on Capital Employed (ROCE)	335.17%	-42.70%	-22.34%